Abstract According to the World Health Organization (WHO) and Centers for Disease Control
and Prevention (CDC), bacterial infections are one of the greatest threats to global health …

Background Helicobacter pylori (H. pylori) is the causative agent of stomach diseases such
as duodenal ulcer and gastric cancer, in this regard incomplete eradication of this bacterium …

Objectives Despite excessive resistance of Helicobacter pylori to clarithromycin among the
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …

Although discovered 40 years ago, Helicobacter pylori infection is still raising diagnostic and
therapeutic problems today. The infection is currently managed based on statements in …

Helicobacter pylori continues to present therapeutic challenges for clinicians across the
world. This review article aims to consolidate current knowledge of H. pylori infection with a …

摘要目的: 分析感染幽门螺旋杆菌(Hp) 的慢性胃炎患者在接受治疗时应用公英益胃汤+
四联疗法后对疗效的影响. 方法: 随机将80 例我院诊治的Hp 阳性的慢性胃炎患者分为对照组与 …

Helicobacter pylori (H. pylori) is a Gram-negative bacterium that infects approximately 50%
of the world population, and currently, no treatment is satisfactory for its management …

摘要目的: 探讨系统性免疫炎症指数(SII), 血小板计数和中性粒细胞与淋巴细胞比值(COP-NLR)
评分与局部晚期鼻咽癌患者临床病理特征和预后的关系. 方法: 选择2015 年1 月到2017 年12 …

Helicobacter pylori infection is one of the most commonly treated infections in
gastroenterology. In the last three decades, due to recurrent or repeated infection, the …

Background: Helicobacter pylori eradication rates has been suboptimal despite multiple-
drug regimens owing to increasing drug resistance. Purpose: To assess the efficacy of a …